Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HKSE:06609'
s PE Ratio (TTM) Range Over the Past 10 Years
Min: 16.33 Med: 19.67 Max: 25.14
Current: 16.33
During the past 7 years, the highest PE Ratio (TTM) of Shanghai HeartCare Medical Technology was 25.14. The lowest was 16.33. And the median was 19.67.
HKSE:06609's PE Ratio (TTM) is ranked better than 70.91% of 440
companies
in the Medical Devices & Instruments industry
Industry Median: 24.77
vs HKSE:06609: 16.33
Shanghai HeartCare Medical Technology (HKSE:06609) PE Ratio (TTM) Explanation
The PE Ratio (TTM) can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio (TTM) is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.
In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio (TTM) is positive. Also for stocks with the same PE Ratio (TTM), the one with faster growth business is more attractive.
If a company loses money, the PE Ratio (TTM) becomes meaningless.
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio (TTM) divided by the growth ratio. He thinks a company with a PE Ratio (TTM) equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio (TTM) of 20, instead of a company growing 10% a year with a PE Ratio (TTM) of 10.
Because the PE Ratio (TTM) measures how long it takes to earn back the price you pay, the PE Ratio (TTM) can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.
Investors need to be aware that the PE Ratio (TTM) can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio (TTM)s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio (TTM) is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio .
PE Ratio (TTM) can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio (TTM).
Shanghai HeartCare Medical Technology PE Ratio (TTM) Related Terms
Shanghai HeartCare Medical Technology PE Ratio (TTM) Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai HeartCare Medical Technology PE Ratio (TTM) Chart
HKSE:06609 vs ABT, SYK, MDT: PE Ratio (TTM) Comparison
For the Medical Devices subindustry, Shanghai HeartCare Medical Technology's PE Ratio (TTM), along with its competitors' market caps and PE Ratio (TTM) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai HeartCare Medical Technology PE Ratio (TTM) vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shanghai HeartCare Medical Technology's PE Ratio (TTM) distribution charts can be found below:
* The bar in red indicates where Shanghai HeartCare Medical Technology's PE Ratio (TTM) falls into.
Shanghai HeartCare Medical Technology PE Ratio (TTM) Calculation
The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.
Shanghai HeartCare Medical Technology's Share Price of today is HK$45.92.
For company reported semi-annually, Shanghai HeartCare Medical Technology's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$2.81.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
There are at least three kinds of PE Ratio (TTM)s used by different investors. They are Trailing Twelve Month PE Ratio (TTM) or PE Ratio (TTM) (TTM), Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio (TTM) based on inflation-adjusted normalized PE Ratio (TTM) is called Shiller PE Ratio, after Yale professor Robert Shiller.
In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.
For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.
Shanghai HeartCare Medical Technology (HKSE:06609) has a PE Ratio (TTM) of 16.33 as of Sep. 03, 2026. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on Shanghai HeartCare Medical Technology and its competitors. This is 17% below median its historical median of 19.67. Over the past decade, Shanghai HeartCare Medical Technology's PE Ratio (TTM) has ranged from 16.33 to 25.14. According to the industry distribution chart, Shanghai HeartCare Medical Technology ranks #128 out of 440 companies in the Medical Devices & Instruments industry, placing it in the top 29.1%.
Is Shanghai HeartCare Medical Technology's PE Ratio (TTM) too high?
Shanghai HeartCare Medical Technology's current PE Ratio (TTM) of 16.33 is 17% below median its 10-year median of 19.67. Over the past 10 years, this metric has ranged from a low of 16.33 to a high of 25.14. The Medical Devices & Instruments industry median PE Ratio (TTM) is 24.77. Shanghai HeartCare Medical Technology's value of 16.33 is 34.1% below this industry median. Based on the distribution chart, Shanghai HeartCare Medical Technology ranks #128 out of 440 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Shanghai HeartCare Medical Technology has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai HeartCare Medical Technology's PE Ratio (TTM) compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Shanghai HeartCare Medical Technology ranks #128 out of 440 companies for PE Ratio (TTM). This puts Shanghai HeartCare Medical Technology in the upper half of its industry. The industry median PE Ratio (TTM) is 24.77. Shanghai HeartCare Medical Technology's value of 16.33 is 34.1% below this benchmark. Historically, Shanghai HeartCare Medical Technology's own PE Ratio (TTM) has ranged from 16.33 to 25.14 over the past decade. While the company's 10-year median is 19.67 vs. the industry median of 24.77, Shanghai HeartCare Medical Technology has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio (TTM) for a Medical Devices & Instruments company?
The median PE Ratio (TTM) among Medical Devices & Instruments companies is 24.77, based on 440 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio (TTM) significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio (TTM) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai HeartCare Medical Technology's current PE Ratio (TTM) of 16.33 is 34.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio (TTM) mean?
A high PE Ratio (TTM) can signal that a stock is expensive relative to its fundamentals. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on Shanghai HeartCare Medical Technology and its competitors. For the Medical Devices & Instruments industry, the median PE Ratio (TTM) is 24.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai HeartCare Medical Technology's current PE Ratio (TTM) is 16.33, which is 17% below median its own 10-year median of 19.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai HeartCare Medical Technology stock overvalued right now?
Based on GuruFocus' analysis, Shanghai HeartCare Medical Technology (HKSE:06609) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$54.97, compared to a current price of HK$45.92 — trading 16.5% below its estimated fair value. The current PE Ratio (TTM) is 16.33, which is 17% below median its 10-year median of 19.67 and 34.1% below the Medical Devices & Instruments industry median of 24.77. Shanghai HeartCare Medical Technology's overall GF Score™ is 80/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio (TTM) calculated?
PE Ratio (TTM) is calculated from a company's financial statements. For Shanghai HeartCare Medical Technology (HKSE:06609), the current PE Ratio (TTM) is 16.33 as of Sep. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai HeartCare Medical Technology (HKSE:06609) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai HeartCare Medical Technology stock appears to be undervalued.
The current stock price of HK$45.92 is trading 16.5% below its estimated GF Value™ of HK$54.97.
GuruFocus considers Shanghai HeartCare Medical Technology to be Modestly Undervalued.
Key valuation signals for HKSE:06609:
PE Ratio (TTM): 16.33 (17% below median its 10-year median of 19.67)
GF Value™: HK$54.97 vs. price of HK$45.92 (16.5% below fair value)
Industry Position: 34.1% below the Medical Devices & Instruments median (#128 of 440)
No single metric tells the full story. See the HKSE:06609 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai HeartCare Medical Technology Corp Ltd is an neuro-interventional medical device company. The company is committed to creating high-quality products for the prevention and treatment of stroke. The company focuses on Research and development, manufacturing and commercialization to fulfill the unmet needs of clinicians and patients to redefine the standard of care, reduce mortality rate, and improve prognosis by continuously launching new medical devices. Geographically, the Group's majority revenue is derived from Chinese Mainland.
80GF Score
Get the complete analysis for HKSE:06609
PE Ratio (TTM) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:06609 has been successfully added to your 
